Next generation of the Kendall™ SCD
Series delivers an all-in-one solution for deep vein thrombosis and
pulmonary embolism prevention
DUBLIN,
Ohio, Nov. 20, 2024 /PRNewswire/
-- Cardinal Health (NYSE: CAH) announced today the U.S. launch
of its Kendall SCD SmartFlow™ Compression System, the next
generation of the Kendall™ Compression Series offering an enhanced
clinician and patient experience. Featuring clinically proven
technology that delivers customized, intermittent pneumatic
compression (IPC) to increase blood flow1 in at-risk
patients, the Kendall SCD SmartFlow™ System is designed to help
prevent venous thromboembolism (VTE) events, as well as enhance
blood circulation and treat pain and swelling related to venous
stasis.
"We're proud to introduce the reimagined Kendall SCD device
to our customers for consistent, effective and reliable compression
therapy, providing clinicians with efficiencies so they can focus
more of their time on direct patient care," said Steve Marshall, senior vice president, Cardinal
Health Global Product Marketing. "We're happy to offer an
easy-to-use device that now has the indication to treat pain and
swelling, which can be common and debilitating symptoms for
patients with insufficient blood flow."
The Kendall SCD SmartFlow™ Compression System leverages Vascular
Refill Detection (VRD) technology with a sequential, gradient and
circumferential sleeve design to move more blood per hour than
uniform compression2. The VRD technology adjusts and
customizes compression cycles to match a patient's unique vascular
refill time, helping the patient receive more compression cycles
over time and ultimately reducing stasis2. The
circumferential sleeve design allows therapy to be applied
regardless of sleeve and tubing position, while the gradient
pressure pattern maximizes blood flow.
Complementing the VRD technology are additional clinical
benefits and features, including proprietary Patient Sensing™
Technology that automatically detects if compression therapy is
being applied and will activate an alert if the system does not
detect a patient present or correct use of the sleeves on the
patient's legs.
"For 40 years, the Cardinal Health Kendall SCD compression
portfolio has served as a trusted solution with healthcare
providers, protecting their patients from experiencing VTE
events," Marshall said. "The new, intuitively designed system
demonstrates our continued commitment to innovation within the
Kendall portfolio and builds on our long-time capabilities in
compression therapy."
The Cardinal Health™ Kendall SCD SmartFlow™ Compression System
is now available for health systems in the U.S. and will be offered
internationally in early 2025. For more information, please visit
us here.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and
specialty products; a global manufacturer and distributor of
medical and laboratory products; a supplier of home-health and
direct-to-patient products and services; an operator of
nuclear pharmacies and manufacturing facilities; and a provider of
performance and data solutions. Our company's customer-centric
focus drives continuous improvement and leads to innovative
solutions that improve people's lives every day. Learn more about
Cardinal Health at cardinalhealth.com and in
our Newsroom.
Contacts
Media: Brittany Julian,
brittany.julian@cardinalhealth.com
Investors: Matt Sims,
matt.sims@cardinalhealth.com
References:
1. Kakkos SK, Nicolaides AN, Griffin M, Geroulakos G. Comparison of
two intermittent pneumatic compression systems. A hemodynamic
study. Int Angiol. 2005;24(4):330-5.
2. Griffin M, et al. Comparison of three intermittent
pneumatic compression systems in patients with varicose veins: A
haemodynamic study. Int Angiol. 2007 Jun;26:158-64.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cardinal-health-launches-kendall-scd-smartflow-compression-system-302310136.html
SOURCE Cardinal Health